Levofloxacin versus azithromycin on the oropharyngeal carriage and selection of antibacterial-resistant streptococci in the microflora of healthy adults

Current Medical Research and Opinion

Volumn 25, Issue 6, 2009, Pages 1461-1467

  Nord, Carl Erik ^a   Peterson, Janet ^b   Ambruzs, Mary ^b   Fisher, Alan C ^b  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b Ortho McNeil Pharmaceutical Incorporated   (United States)

Author keywords

Azithromycin; Levofloxacin; Oral microflora; Resistance; Streptococci

Indexed keywords

AZITHROMYCIN; LEVOFLOXACIN;

ABDOMINAL PAIN; ADULT; ALPHA HEMOLYTIC STREPTOCOCCUS; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DIZZINESS; FEMALE; FLATULENCE; HEADACHE; HUMAN; HUMAN EXPERIMENT; MALE; MICROFLORA; MINIMUM INHIBITORY CONCENTRATION; NAUSEA; NORMAL HUMAN; OROPHARYNX; RANDOMIZED CONTROLLED TRIAL; STREPTOCOCCUS; STREPTOCOCCUS MITIS; STREPTOCOCCUS SALIVARIUS; STREPTOCOCCUS SANGUINIS; THROAT CULTURE;

ADOLESCENT; ADULT; ANTI-BACTERIAL AGENTS; AZITHROMYCIN; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FEMALE; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MICROBIAL VIABILITY; OFLOXACIN; OROPHARYNX; STREPTOCOCCACEAE; STREPTOCOCCAL INFECTIONS; YOUNG ADULT;

EID: 67649443934     PISSN: 03007995     EISSN: 14734877     Source Type: Journal    
DOI: 10.1185/03007990902953468     Document Type: Article

References (23)

1. Felmingham D. Comparative antimicrobial susceptibility of respiratory tract pathogens. Chemotherapy 2004;50(Suppl 1):3-10 (Pubitemid 39179214)
2. Ortho-McNeil-Janssen Pharmaceuticals I. TRUST 12, 2008. Data on file. Ortho-McNeil-Janssen Pharmaceuticals, Inc. 2008 file number 5004-5035
3. Klugman KP, Lonks JR. Hidden epidemic of macrolide-resistant pneumococci. Emerg Infect Dis 2005;11:802-807 (Pubitemid 40720838)
4. Karlowsky JA, Thornsberry C, Jones ME, et al. Factors associated with relative rates of antimicrobial resistance among Streptococcus pneumoniae in the United States: results from the TRUST Surveillance Program (1998-2002). Clin Infect Dis 2003;36:963-970
5. Lister PD. Pharmacodynamics of 750mg and 500mg doses of levofloxacin against ciprofloxacin-resistant strains of Streptococcus pneumoniae. Diagn Microbiol Infect Dis 2002;44:43-49
6. Dunbar LM, Wunderink RG, Habib MP, et al. High-dose, short-course levofloxacin for community-acquired pneumonia: a new treatment paradigm. Clin Infect Dis 2003;37:752-760 (Pubitemid 37153652)
7. Zithromax [package insert]. New York, NY: Pfizer Labs, 2007.
8. Kastner U, Guggenbichler JP. Influence of macrolide antibiotics on promotion of resistance in the oral flora of children. Infection 2001;29:251-256 (Pubitemid 32929629)
9. Levofloxacin [package insert]. Raritan, NJ: Ortho-McNeil Pharmaceuticals, Inc., 2008.
10. Baquero F. Evolving resistance patterns of Streptococcus pneumoniae: a link with long-acting macrolide consumption? J Chemother 1999;11(Suppl 1):35-43
11. Amsden GW. Pneumococcal macrolide resistance - myth or reality? J Antimicrob Chemother 1999;44:1-6
12. Cizman M, Pokorn M, Seme K, et al. Influence of increased macrolide consumption on macrolide resistance of common respiratory pathogens. Eur J Clin Microbiol Infect Dis 1999;18:522-524 (Pubitemid 29531197)
13. Drusano GL, Craig WA. Relevance of pharmacokinetics and pharmacodynamics in the selection of antibiotics for respiratory tract infections. J Chemother 1997;9(Suppl 3):38-44 (Pubitemid 27294747)
14. Malhotra-Kumar S, Lammens C, Coenen S, et al. Effect of azithromycin and clarithromycin therapy on pharyngeal carriage of macrolide-resistant streptococci in healthy volunteers: a randomised, double-blind, placebo-controlled study. Lancet 2007;369:482-490 (Pubitemid 46209315)
15. Leclercq R. Mechanisms of resistance to macrolides and lincosamides: nature of the resistance elements and their clinical implications. Clin Infect Dis 2002;34:482-492 (Pubitemid 34112269)
16. Clinical and Laboratory Standards Institute. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically; Approved Standard, 7th Edition. Wayne, PA: Clinical and Laboratory Standards Institute, 2006
17. Principi N, Marchisio P, Schito GC, et al. Risk factors for carriage of respiratory pathogens in the nasopharynx of healthy children. Ascanius Project Collaborative Group. Pediatr Infect Dis J 1999;18:517-523 (Pubitemid 29277615)
18. Mandell LA, Wunderink RG, Anzueto A, et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis 2007;44(Suppl 2):S27-S72 (Pubitemid 46290553)
19. Jonsson M, Swedberg G. Macrolide resistance can be transferred by conjugation from viridans streptococci to Streptococcus pyogenes. Int J Antimicrob Agents 2006;28:101-103 (Pubitemid 44108614)
20. Johnson DM, Stilwell MG, Fritsche TR, et al. Emergence of multidrug-resistant Streptococcus pneumoniae: report from the SENTRY Antimicrobial Surveillance Program (1999-2003). Diagn Microbiol Infect Dis 2006;56:69-74
21. Doern GV, Heilmann KP, Huynh HK, et al. Antimicrobial resistance among clinical isolates of Streptococcus pneumoniae in the United States during 1999-2000, including a comparison of resistance rates since 1994-1995. Antimicrob Agents Chemother 2001;45:1721-1729
22. Blondeau JM. Differential impact of macrolide compounds in the selection of macrolide nonsusceptible Streptococcus pneumoniae. Therapy 2005;2:813-818 (Pubitemid 41715271)
23. Whatmore AM, Efstratiou A, Pickerill AP, et al. Genetic relationships between clinical isolates of Streptococcus pneumoniae, Streptococcus oralis, and Streptococcus mitis: characterization of 'Atypical' pneumococci and organisms allied to S. mitis harboring S. pneumoniae virulence factor-encoding genes. Infect Immun 2000;68:1374-1382